SB

Samsara BioCapital Portfolio holdings

AUM $489M
This Quarter Return
-7.48%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$484M
AUM Growth
+$484M
Cap. Flow
+$77.2M
Cap. Flow %
15.95%
Top 10 Hldgs %
73.12%
Holding
58
New
4
Increased
1
Reduced
4
Closed
2

Top Buys

1
MLYS icon
Mineralys Therapeutics
MLYS
$70.8M
2
AVDL
Avadel Pharmaceuticals
AVDL
$6.87M
3
ATYR
aTyr Pharma
ATYR
$3.68M
4
INZY
Inozyme Pharma
INZY
$2.89M
5
LPTX icon
Leap Therapeutics
LPTX
$288K

Top Sells

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$2.95M
2
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
$2.16M
3
ACLX icon
Arcellx
ACLX
$1.47M
4
SWTX
SpringWorks Therapeutics
SWTX
$578K
5
BCEL
Atreca, Inc. Class A Common Stock
BCEL
$153K

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IMTX icon
26
Immatics
IMTX
$669M
$3.42M 0.71%
495,000
– –
INZY
27
DELISTED
Inozyme Pharma
INZY
$2.89M 0.6%
+504,407
New +$2.89M
DAWN icon
28
Day One Biopharmaceuticals
DAWN
$770M
$2.63M 0.54%
196,425
– –
TNGX icon
29
Tango Therapeutics
TNGX
$723M
$2.49M 0.51%
630,000
– –
DBTX
30
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$2.42M 0.5%
801,629
– –
TERN icon
31
Terns Pharmaceuticals
TERN
$647M
$2.4M 0.5%
202,348
– –
SYRS
32
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.35M 0.49%
881,450
– –
IGMS
33
DELISTED
IGM Biosciences
IGMS
$2.13M 0.44%
154,664
– –
IOBT icon
34
IO Biotech
IOBT
$114M
$1.89M 0.39%
1,008,437
– –
ELEV
35
DELISTED
Elevation Oncology
ELEV
$1.58M 0.33%
830,565
– –
BOLT icon
36
Bolt Biotherapeutics
BOLT
$9.46M
$1.46M 0.3%
1,049,153
– –
EYPT icon
37
EyePoint Pharmaceuticals
EYPT
$820M
$1.41M 0.29%
480,000
– –
VTVT icon
38
vTv Therapeutics
VTVT
$47.1M
$1.32M 0.27%
1,635,509
– –
ALXO icon
39
ALX Oncology
ALXO
$54.6M
$1.19M 0.25%
262,786
– –
TIL icon
40
Instil Bio
TIL
$198M
$1.18M 0.24%
1,788,280
– –
VIRX
41
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.1M 0.23%
689,709
– –
ALLK
42
DELISTED
Allakos
ALLK
$766K 0.16%
172,089
– –
EQ icon
43
Equillium
EQ
$63.6M
$449K 0.09%
615,541
– –
ATXS icon
44
Astria Therapeutics
ATXS
$386M
$333K 0.07%
25,000
– –
KLRS
45
Kalaris Therapeutics, Inc. Common Stock
KLRS
$115M
$324K 0.07%
82,336
– –
BCEL
46
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$300K 0.06%
262,827
-134,008
-34% -$153K
LPTX icon
47
Leap Therapeutics
LPTX
$12.3M
$288K 0.06%
+846,038
New +$288K
SYRE icon
48
Spyre Therapeutics
SYRE
$1.02B
$256K 0.05%
883,720
– –
SNCE
49
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$253K 0.05%
900,000
– –
KALA icon
50
KALA BIO
KALA
$92.2M
$181K 0.04%
12,024
– –
1
2
3